Please assess the completion status of the following clinical trial:

Trial Title: Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing SVG PCI with a target vessel reference diameter ≤ 5.5 mm (visual estimate)~* Documented silent ischemia, stable angina pectoris Canadian Cardiovascular Society (CCS) class I to IV, or acute coronary syndrome~Exclusion Criteria:~* Previous stent implantation anywhere in the target SVG~* Concomitant native vessel PCI~* SVG age \<6 months~* Arterial grafts~* Oral anticoagulation~* Platelet count \<100x109/L or \>700x109/L, white blood cell count \<3000 cells/mm3~* Any major non-cardiac condition with a life expectancy \<12 months~* Planned elective surgery in the next 12 months~* Known allergies against the components tested~* Enrolled in other study~* No consent~* Patients unlikely to comply to the study treatment and the follow-up visits~* Age \<18 years~* Known pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Percutaneous coronary intervention
- 2 (Type: PLACEBO_COMPARATOR): Percutaneous coronary intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).